ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 以前(平成9〜22年度)厚生労働科学研究費補助金の概要 > 平成22年度厚生労働科学研究費補助金の概要 > 中間・事後評価委員会名簿 > 障害者対策総合研究事業中間・事後評価委員名簿 (神経・筋疾患分野)

障害者対策総合研究事業中間・事後評価委員名簿 (神経・筋疾患分野)

(○:委員長)

葛原 茂樹 鈴鹿医療科学大学保健衛生学部医療福祉学科特任教授
神経変性疾患、痴呆性疾患、医原性神経疾患、脳血管障害
Kuzuhara S, Kokubo Y, Sasaki R, Narita Y, Yabana T, Hasegawa M, Iwatsubo T: Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii peninsula of Japan: clinical and neuropathological study and tau analysis.  Ann Neurol  49:501-511, 2001
Morimoto S, Kuzuhara S, Kokubo Y: Increased  oxidative stress in patients with amyotrophic lateral sclerosis/parkinsonism-dementia comlex in the Kii Peninsula, Japan.  Mov Disord 24:123-126, 2008
Tomiyama H, Kokubo Y, Sasaki R, Li Y, Imamichi Y, Funayama M, Mizuno Y, Hattori N, Kuzuhara S: Mutation analyses in amyotrophic lateral sclerosis/parkinsonism-dementia complex of the Kii peninsula, Japan. Mov Disord 23:2344-2348, 2008
 
篠原 幸人 国家公務員共済組合連合会立川病院 院長
神経内科学
Shinohara Y: Hemorrhagic stroke syndrome: Clinical manifestation of intracerebral and subarachnoid hemorrhage.
In “Handbook of Clinical Neuroloy, Vol. 93, Chap 28”, ed by Mark Fisher.
Elsevier, Edinburgh. pp577-594, 2009
Shinohara Y, Nishimaru K, Sawada T, Terashi A, Handa S, Hirai S, Hayashi K, Tohgi H, Fukuuchi Y, Uchiyama S, Yamaguchi T, Kobayashi S, Kondo K, Otomo E, Gotoh F, for the S-ACCESS Study Group: Sarpogrelate-aspirin comparative clinical study for efficacy and safety in secondary prevention of cerebral infarction. (S-ACCESS) A randomized, double-blind, aspirin-controlled trial.
Stroke 39:1827-1833, 2008
Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tushima M, Koretsune Y, Sawada T, Hamada C, for the CSPS 2 group: Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
Lancet Neurol 9:959-968, 2010
 
清水 夏繪 帝京平成大学地域医療学部学部長
神経内科学、神経眼科学
A sporadic case of dentatorubral pallidoluysian atrophy (DRPLA) with CAG repeat expansion but no clinical abnormalities in the father. Shimizu N, Yamami T, Nakayama M, Ikeuchi T, Koide R, Tsuji S. J Neurol Neurosurg Psychiatry 1996 Jan;61(1):113-114.
急性期脳卒中片麻痺患者における健側上肢の運動機能について. 金田建志、清水夏繪.リハビリテーション医学 2002 Feb;39(2):95-98
Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule-associated with protein tau): A comparison of N-Isopropyl-p-[(123)I]-iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy. Ogaki K, Motoi Y, Li Y, Tomiyama H, Shimizu N, Takanashi M, Nakanishi A, Yokoyama K, Hattori N. Mov Disord. 2010 Dec17;[Epub ahead of print]
 
高守 正治 金沢西病院脳神経センター長 金沢大学名誉教授
神経免疫学、神経生理学
Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis. Takamori M. J Neuroimmunol. 2008 Sept; 201-202: 145-152.
Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis. Takamori M. J Neuroimmunol. 2008 Aug; 200(1-2): 142-144.
Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Takamori M, Motomura M, Fukudome T, Yoshikawa H. Eur J Neurol 2007 Nov; 14(11): 1230-1235.
 
田村 晃 富士脳障害研究所附属病院院長
脳神経外科
Thalamic atrophy following cerebral infarction in the territory of the middle cerebral artery. Tamura A, Tahira Y, Nagashima H, Kirino T, Gotoh O, Hojo S, Sano K. Stroke 1991; 22:615-618
Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Nakatomi H, Kuriu T. Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M. Cell 2002; 110:429-441
「EBMに基づく脳神経疾患の基本治療指針」田村晃、松谷雅生、清水輝夫編著、メジカルビュー社、(2006).
 
西澤 正豊 新潟大学脳研究所神経内科学分野教授
神経内科学
Yanagawa K, Kawachi I, Yokoseki A, Arakawa M, Hasegawa A, Ito Y, Kojima N, Koike R, Tanaka K, Kosaka T, Tan C-F, Toyoshima Y, Kakita A, Tsujita M, Sakimura K, Takahashi H, Nishizawa M: Clinical course and pathological characterization of a limited form of neuromyelitis optica with myelitis: homogeneity of pathogenesis and heterogeneity of treatment response through long-term courses of neuromyelitis optica. Neurology 2009; 73 (20): 1628-1637. PMID: 19917985
Kanazawa M, Shimohata T, Toyoshima Y, Tada M, Kakita A, Morita T, Ozawa T, Takahashi H, Nishizawa M: Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study. Mov Disord 2009; 24 (9): 1312-1318. PMID: 19412943
Shimohata T, Shinoda H, Nakayama H, Ozawa T, Terajima K, Yoshizawa H, Matsuzawa Y, Onodera O, Naruse S, Tanaka K, Takahashi S, Gejyo F, Nishizawa M.: Daytime hypoxemia, sleep-disordered breathing, and laryngopharyngeal findings in multiple system atrophy. Arch Neurol 2007; 64 (6): 856-861, PMID: 17562934
 
御子柴 克彦 理化学研究所グループディレクター
脳神経科学
Futatsugi, A., Nakamura, T., Yamada, M. K.,Ebisui, E., Nakamura, K., Uchida, K., Kitaguchi, T., Takahashi-Iwanaga, H., Noda, T., Aruga, J. & Mikoshiba, K.: IP3 Receptor Types 2 and 3 mediate exocrine secretion underlying energy metabolism Science 309: 2232-2234 (2005)
Higo, T., Hattori, M., Nakamura, T., Natsume, T., Michikawa, T & Mikoshiba,K.:Subtype-specific and ER-lumenal-environment-dependent Regulation of Inositol 1,4,5-Trisphosphate Receptor Type 1 by ERp44. Cell 120: 85-98 (2005)
Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N. & Mikoshiba, K.:  Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342: 32-38 (1989)

(官職指定)
大臣官房厚生科学課長
健康局疾病対策課長
医政局政策医療課長

ホーム > 政策について > 分野別の政策一覧 > 他分野の取り組み > 研究事業 > 以前(平成9〜22年度)厚生労働科学研究費補助金の概要 > 平成22年度厚生労働科学研究費補助金の概要 > 中間・事後評価委員会名簿 > 障害者対策総合研究事業中間・事後評価委員名簿 (神経・筋疾患分野)

ページの先頭へ戻る